Loading insider details...
Beta
Latest Form 4 (Jun 30, 2026): Exercise/Conversion of 10,000 GLUE shares, $41.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 30, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | Exercise/Conversion | 10,000 | $41.6K |
| Jun 12, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/Award | 25,800 | n/a |
| May 22, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | Exercise/Conversion | 10,000 | $41.6K |
| Jun 16, 2025 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/Award | 30,700 | n/a |
| Jul 16, 2024 | PALATIN TECHNOLOGIES INC (PTN) | Grant/Award | 12,000 | n/a |
| Jun 13, 2024 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/Award | 22,100 | n/a |
| Jul 26, 2023 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/Award | 41,000 | n/a |
| Jun 22, 2023 | PALATIN TECHNOLOGIES INC (PTN) | Grant/Award | 10,000 | n/a |
| Jun 24, 2022 | PALATIN TECHNOLOGIES INC (PTN) | Grant/Award | 73,000 | n/a |
| Jun 24, 2021 | PALATIN TECHNOLOGIES INC (PTN) | Grant/Award | 77,000 | n/a |